OLK
Olink Holding AB ADR
NASDAQ: OLK · HEALTHCARE · DIAGNOSTICS & RESEARCH
$26.08
+0.00% today
Updated 2026-04-30
Market cap
$3.24B
P/E ratio
—
P/S ratio
18.98x
EPS (TTM)
$-0.27
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
Olink Holding AB ADR (OLK) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-19.70%
Operating margin
-86.80%
ROE
-7.03%
ROA
-6.56%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $41.69M | $-17.88M | 68.78% | -25.58% | -42.88% |
| 2020 | $54.07M | $-6.78M | 67.71% | -11.25% | -12.54% |
| 2021 | $94.97M | $-38.34M | 61.29% | -47.02% | -40.37% |
| 2022 | $139.85M | $-12.85M | 67.57% | -21.88% | -9.19% |
| 2023 | $169.91M | $-31.66M | 58.19% | -29.39% | -18.63% |